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CASE REPORT A 47-year-old mother of two
was seen in the colposcopy clinic in November
1994 with ahistory oftwo abnormal smears. The
first in June 1993 showed severe inflammation,
and the repeat smear ayearlater showed atypical
glandular cells. She had been post- menopausal
for two years and had no gynaecological
symptoms. In June 1993, a left mastectomy with
axillary node sampling had been performed for a
well-differentiated, infiltrating ductalcarcinoma
ofthebreast (TI NO MO). There was extension to
the pectoralis major muscle but no lymph node
involvement. She had been on Tamoxifen 20 mg
daily since the operation.
At colposcopy the vagina was atrophic, and the
epithelium was sloughing. The cervix felt hard
and irregular. There was a large iodine-negative
area but no evidence of cervical inter epithelial
neoplasia. She was admitted for examination
underanaesthesiaandcervicalbiopsy. Theuterus
andadnexaewereunremarkableandnoinduration
could be felt beyond the cervix. A 1 x 0.5 cm
biopsy showed extensive involvement of the
cervix with well-differentiated adenocarcinoma
and lymphatic permeation. A computerised
tomography scanofthechest, abdomenandpelvis
was normal as were a bone scan, magnetic
resonanceimagingofthepelvisandliverfunction
tests.
A total abdominal hysterectomy and bilateral
salpingo-oophorectomy were performed in
January 1995. Histology confirmed metastatic
breast carcinoma confined to the cervix. Post
operative recovery was complicated by a lower
respiratory tract infection which responded to
antibiotics. She received 22 fractions of
radiotherapytoheranterior,posterior,rightlateral
and left lateralpelvis (4400centiGray), followed
by six courses ofchemotherapy consisting of 5-
fluouracil,epirubicinandcyclophosphamide. She
remainswelltodatealmost4yearsafteroperation.
DISCUSSION
The cervix is not usually suspected of being a
potential site for metastatic disease, is less likely
to be examined at post-mortem, and
adenocarcinoma metastatic to the uterine cervix
is rare. The reasons for its rarity are that the
cervix is a small target organ with a small blood
supply and only an afferent Lymph drainage
system. Further, the fibromuscular tissue of the
cervix is apoorculture medium. The response of
the cervix to metastatic disease is fibrous
proliferation and an inflammatory cellular
reaction which may explain the findings in this
case of an expanded, indurated cervix.
Most extragenital metastases to the cervix arise
fromprimarytumoursofthegastrointestinaltract.'
Other primary sites include lung, pancreas,
melanoma,urethraandbreast. Breastcanceroften
metastasises to the ovary butrarely to the cervix.
It has been estimated that only 4.5% of cervical
secondaries arise from breast primaries.2
Breastcancerisoneofthemostcommontumours
affecting women, representing about 30% of all
female malignancies. In 1941, 34 of 59 (58%)
cases of carcinoma metastatic to the uterus and
cervixoriginatedinthebreast.3Regrettablythese
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TABLE
Details of27 cases ofbreast cancer metastasising to the uterine cervix.
Case Reference Age Interval Symptoms Survival
No. months months
Cruz 1954
Wallach & Edberg 1957
Song 1963
, ,)
, ,
Dance & Fullmer 1970
Cohan & Kaplan 1984
Di Bonito et al 1985
47
73
45
49
51
63
74
60
6
0
0
48
48+
12
- 108
5 Lemoine & Hall 1986
Way 1980
Korhonen & Stenback 1984
Yazigi et al 1988
17 Taylor & Torode 1990
Campora et al 1991
Fiorella et al 1992
Current case
- 12
_ 5
- 36
45 36
60 58
39 -2
71 58
49 2
63 8
49 0
49 42
38 0
84 444
50 33
57 83
54 0
47 17
menorrhagia
facial palsy
smear + IMB
IMB
smear+ IMB
smear + nodules
PMB
PVB
PVB
PVB
none
PMB
PMB
IMB
PMB
PVB
smear + PMB
PVB
PVB
breast lump
PMB
IMB + polyp
abdominal pain
smear + PMB
smear
Interval = interval between diagnosis of primary breast cancer and secondary cervical cancer
IMB = intermenstrual bleeding. PMB=post-menopausal bleeding. PVB=peri-vaginal bleeding.
Alive = alive at time of report
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9
10
11
12
13
14
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
15
16
6
alive
0.5
alive
alive
4
alive
alive
108
I?
12
5
36
1.5
4
6
14
155
alive
14
2
15
1
alive
6
6
alive
18
4
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cases were poorly documented, and no
differentiation was made between the cervix and
thebodyoftheuterus. Sincethenafurthertwenty-
seven cases ofbreast carcinoma metastasising to
thecervix(includingthisone)havebeenreported
in the literature. Age at presentation, interval
between primary and secondary diagnosis,
presentingsymptomsandsurvivalaresummarised
in the Table.
Most cases presented with abnormal vaginal
bleeding. Seven cases had abnormal cervical
cytology but only the current case presented
solelywithanabnormalsmear.Atypicalglandular
cells in a cervical smear suggest endometrial
carcinoma, but they may represent any
adenocarcinoma primary. The cytological
appearances, inparticulartheabsenceofatumour
diathesis, may indicate an extragenital site.4 In
onecasethecervical metastasis wasdetectedtwo
months before the breast cancer could be
identified. However,theaverageintervalbetween
primary and secondary diagnosis was 44.5
months. In comparison to other primaries the
relatively long interval for breast disease has
already been highlighted.5
In most reports there were multiple metastases.
In this case and in one other report 6 the cervix
was the only site ofsecondary disease. On initial
presentation it is easy to mistake cervical
metastases as primary disease because of the
common presentation of abnormal vaginal
bleeding, abnormal cervical smear and an
abnormal-looking cervix. The histological
diagnosis of a secondary deposit makes an
important difference to treatment. This patient
had adjuvant radiotherapy and chemotherapy
which would not have been usual management
for a primary adenocarcinoma of the cervix.
Had the cervix had been normal, the atypical
glandularcells inthe smearmighthave indicated
an adenocarcinoma further up the genital tract.
The annual incidence of endometrial carcinoma
at ages 55-84 in Europe is 0.5 per 1000, which is
doubled after two years oftamoxifen medication
andapproximately quadrupled afterfive years of
tamoxifen.7Abnormalvaginalbleedinginwomen
taking tamoxifen needs rigorous investigation
butthebenefitsofscreeningasymptomatic women
for endometrial carcinoma with transvaginal
ultrasound or hysteroscopy have yet to be
determined.8
C) The Ulster Medical Society, 1999.
We suggest that any woman with a history of
breast carcinoma who presents with
gynaecological symptoms should be screened
bothfortheiatrogeniceffectsoftamoxifentherapy
ontheendometrium andformetastatic disease of
the cervix. Investigation of extragenital sites is
particularly relevant if adenocarcinoma of the
cervix is suspected.
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